What monitoring plan is typical after starting osteoporosis treatment?

• A. Periodic clinical evaluation; repeat DEXA every 1-2 years; monitor labs as indicated; assess adherence and adverse effects
• B. Monitor only self-reported symptoms
• C. Repeat DEXA every 10 years
• D. No follow-up is necessary

Answer: (A)

After starting osteoporosis treatment, the goal is to track how well the therapy is working, ensure safety, and confirm the patient stays on course. Regular clinical follow-ups help detect new fractures, assess falls risk, and check how well the patient tolerates and adheres to the regimen. An objective measure of bone density, such as a repeat DEXA scan every 1–2 years in the early phase, provides concrete evidence of change (increase or stabilization in bone density) and helps guide ongoing management. Labs should be checked as indicated to monitor calcium and vitamin D status, renal function, and other metabolic factors that influence bone health, with therapy adjusted if needed. Adherence and adverse effects must be reviewed so problems can be addressed promptly and treatment continued safely. Relying only on symptoms misses silent progression, waiting a decade between DEXA scans is too infrequent, and no follow-up neglects essential safety and efficacy checks.